Tong Ren Tang Healthcare says trading expected to begin July 7

Beijing Tong Ren Tang Healthcare Investment Co. Ltd. (2667.HK) has announced that completion of its initial public offering on the Hong Kong Stock Exchange. The company, a subsidiary of the TRT Group and a leading provider of Traditional Chinese Medicine (TCM) healthcare services, launched its IPO on March 20, 2026, with plans to raise up to HK$897.7 million by offering 108.15 million shares at a price range of HK$7.30 to HK$8.30 per share.

Tong Ren Tang Healthcare operates a network of 12 self-owned medical institutions, 10 managed offline institutions, and an internet hospital, making it largest non-public TCM hospital group in China by patient visits as of 2024. The company aims to acquiring and building 10 medical institutions by 2029. Proceeds from the IPO will be allocated to brand promotion, business development, working capital, strategic acquisitions, and debt repayment.

The company’s financial performance has shown steady growth, with revenue increasing from 911 million yuan in 2022 to 1.18 billion yuan in 2024. TCM healthcare services account for approximately 84% of its revenue, driven by outpatient care and related services.